Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta... Read more
Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no... Read more
Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab... Read more
The Center for Medicine in the Public Interest is a nonprofit, nonpartisan research and educational organization that seeks to advance the discussion and development of patient-centered health care.
